Literature DB >> 10454514

Divalent cations modulate N-methyl-D-aspartate receptor function at the glycine site.

H Hashemzadeh-Gargari1, T R Guilarte.   

Abstract

The modulation of the N-methyl-D-aspartate (NMDA) receptor (NMDAR) by divalent cations was examined using (+)-5-methyl-10, 11-dihydro-5H-dibenzo[a,d]cyclohepten 5,10-imine maleate ([(3)H]MK-801) binding as a functional indicator of NMDAR function. Ca(2+) and Mg(2+) produce a biphasic effect on the binding of [(3)H]MK-801 to the NMDAR channel in extensively washed adult rat brain membranes. Concentrations of Ca(2+) and Mg(2+) between 1 and 600 microM potentiate binding, but higher concentrations inhibit binding. The potentiating effect of Ca(2+) and Mg(2+) on [(3)H]MK-801 binding is due to an increase in the maximal number of binding sites (B(max)) with no effect on binding affinity (K(d)). Ca(2+)- and Mg(2+)induced potentiation is the result of an apparent increase in the affinity of the NMDAR for glycine. The ontogeny of NMDAR potentiation by Ca(2+) and Mg(2+) was also investigated. The number of [(3)H]MK-801 binding sites associated with divalent cation potentiation are present at low levels shortly after birth, and increase to peak level at 17 days of age before declining to adult levels. The potency of Ca(2+) and Mg(2+) to stimulate [(3)H]MK-801 binding did not change as a function of age. Lead (Pb(2+)) and zinc (Zn(2+)), potent inhibitors of the NMDAR, antagonize NMDAR potentiation by Ca(2+) and Mg(2+). These findings indicate that divalent cations differentially regulate NMDAR function by modulation of the glycine site. The NMDAR glycine site may be important in the regulation of glutamatergic neurotransmission by physiologically and toxicologically relevant cations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10454514

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review.

Authors:  Andreas M Grabrucker; Magali Rowan; Craig C Garner
Journal:  Drug Deliv Lett       Date:  2011-09

Review 2.  Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses.

Authors:  Tomás R Guilarte; Mark Opler; Mikhail Pletnikov
Journal:  Neurotoxicology       Date:  2011-12-09       Impact factor: 4.294

Review 3.  Molecular targets of lead in brain neurotoxicity.

Authors:  Carla Marchetti
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

4.  Chronic exposure of mutant DISC1 mice to lead produces sex-dependent abnormalities consistent with schizophrenia and related mental disorders: a gene-environment interaction study.

Authors:  Bagrat Abazyan; Jenifer Dziedzic; Kegang Hua; Sofya Abazyan; Chunxia Yang; Susumu Mori; Mikhail V Pletnikov; Tomas R Guilarte
Journal:  Schizophr Bull       Date:  2013-05-28       Impact factor: 9.306

5.  Manganese inhibits NMDA receptor channel function: implications to psychiatric and cognitive effects.

Authors:  Tomás R Guilarte; Ming-Kai Chen
Journal:  Neurotoxicology       Date:  2007-06-26       Impact factor: 4.294

6.  Interaction between metals and chelating agents affects glutamate binding on brain synaptic membranes.

Authors:  Félix Antunes Soares; Marcelo Farina; Francielli Weber Santos; Diogo Souza; João Batista Teixeira Rocha; Cristina Wayne Nogueira
Journal:  Neurochem Res       Date:  2003-12       Impact factor: 3.996

7.  Metal toxicity at the synapse: presynaptic, postsynaptic, and long-term effects.

Authors:  Sanah Sadiq; Zena Ghazala; Arnab Chowdhury; Dietrich Büsselberg
Journal:  J Toxicol       Date:  2012-01-12

8.  Prenatal lead exposure and schizophrenia: a plausible neurobiologic connection.

Authors:  Tomás R Guilarte
Journal:  Environ Health Perspect       Date:  2004-09       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.